Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose, Randomized, Double-Blind, Single-Period, Parallel Clinical Study Comparing the Pharmacokinetics of SHR-8068 Injection and Ipilimumab (YERVOY®) in Healthy Chinese Male Participants

NCT07852325 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT07852325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose, Randomized, Double-Blind, Single-Period, Parallel Clinical Study Comparing the Pharmacokinetics of SHR-8068 Injection and Ipilimumab (YERVOY®) in Healthy Chinese Male Participants
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Phase 1
Overall status
Completed
Start date
January 7, 2024
Completion date
December 19, 2024
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants